Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.44874276 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.44874276 |
3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.91725716 |
4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.91725716 |
5 | modulation by symbiont of host immune response (GO:0052553) | 3.91725716 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 3.91725716 |
7 | modulation by symbiont of host defense response (GO:0052031) | 3.91725716 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.91725716 |
9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.87551271 |
10 | NIK/NF-kappaB signaling (GO:0038061) | 3.87454300 |
11 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.44454593 |
12 | cellular response to type I interferon (GO:0071357) | 3.39416177 |
13 | type I interferon signaling pathway (GO:0060337) | 3.39416177 |
14 | positive regulation of histone deacetylation (GO:0031065) | 3.35409285 |
15 | response to type I interferon (GO:0034340) | 3.34040829 |
16 | pentose-phosphate shunt (GO:0006098) | 3.28985754 |
17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.26738468 |
18 | COPI coating of Golgi vesicle (GO:0048205) | 3.24309303 |
19 | Golgi transport vesicle coating (GO:0048200) | 3.24309303 |
20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22593663 |
21 | heterochromatin organization (GO:0070828) | 3.21075989 |
22 | GDP-mannose metabolic process (GO:0019673) | 3.14904200 |
23 | neutrophil activation involved in immune response (GO:0002283) | 3.14895338 |
24 | negative regulation of cell killing (GO:0031342) | 3.09616867 |
25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.09616867 |
26 | DNA unwinding involved in DNA replication (GO:0006268) | 3.08808185 |
27 | regulation of translational fidelity (GO:0006450) | 3.08691784 |
28 | response to laminar fluid shear stress (GO:0034616) | 3.03022948 |
29 | detection of bacterium (GO:0016045) | 3.02984968 |
30 | detection of other organism (GO:0098543) | 2.95830155 |
31 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.91656790 |
32 | positive regulation of interferon-alpha production (GO:0032727) | 2.90324787 |
33 | low-density lipoprotein particle clearance (GO:0034383) | 2.89294944 |
34 | protein maturation by protein folding (GO:0022417) | 2.88380490 |
35 | negative regulation of phagocytosis (GO:0050765) | 2.86693483 |
36 | glycosphingolipid catabolic process (GO:0046479) | 2.84783116 |
37 | NADPH regeneration (GO:0006740) | 2.83942645 |
38 | RNA stabilization (GO:0043489) | 2.82272099 |
39 | mRNA stabilization (GO:0048255) | 2.82272099 |
40 | myeloid dendritic cell differentiation (GO:0043011) | 2.82097799 |
41 | regulation of superoxide anion generation (GO:0032928) | 2.81901832 |
42 | modulation by symbiont of host cellular process (GO:0044068) | 2.80852684 |
43 | regulation of interferon-alpha production (GO:0032647) | 2.78706598 |
44 | maternal placenta development (GO:0001893) | 2.78310147 |
45 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.75330365 |
46 | protein localization to kinetochore (GO:0034501) | 2.74995873 |
47 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.74070884 |
48 | cellular response to virus (GO:0098586) | 2.73381591 |
49 | immunoglobulin mediated immune response (GO:0016064) | 2.72477374 |
50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.69814143 |
51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.68227128 |
52 | regulation of integrin activation (GO:0033623) | 2.66709215 |
53 | hepatocyte apoptotic process (GO:0097284) | 2.64589812 |
54 | modulation by virus of host process (GO:0019054) | 2.61820991 |
55 | positive regulation of protein deacetylation (GO:0090312) | 2.59664144 |
56 | regulation of necrotic cell death (GO:0010939) | 2.59576139 |
57 | myeloid dendritic cell activation (GO:0001773) | 2.59231017 |
58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.58781647 |
59 | glycolipid catabolic process (GO:0019377) | 2.56356649 |
60 | barbed-end actin filament capping (GO:0051016) | 2.54326411 |
61 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54124226 |
62 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.53842389 |
63 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.53611454 |
64 | * negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.52738937 |
65 | nuclear pore complex assembly (GO:0051292) | 2.51827604 |
66 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.49961747 |
67 | negative regulation of interleukin-12 production (GO:0032695) | 2.49858823 |
68 | actin nucleation (GO:0045010) | 2.48747957 |
69 | regulation of defense response to virus by virus (GO:0050690) | 2.46484802 |
70 | positive regulation of lamellipodium assembly (GO:0010592) | 2.45441239 |
71 | macrophage activation involved in immune response (GO:0002281) | 2.44416432 |
72 | negative regulation of viral release from host cell (GO:1902187) | 2.44376894 |
73 | regulation of podosome assembly (GO:0071801) | 2.43867938 |
74 | mitotic nuclear envelope disassembly (GO:0007077) | 2.43597725 |
75 | germ cell migration (GO:0008354) | 2.43087512 |
76 | NADH metabolic process (GO:0006734) | 2.41486567 |
77 | pyrimidine-containing compound salvage (GO:0008655) | 2.41160822 |
78 | pyrimidine nucleoside salvage (GO:0043097) | 2.41160822 |
79 | tolerance induction (GO:0002507) | 2.40610349 |
80 | regulation of necroptotic process (GO:0060544) | 2.39872676 |
81 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39523121 |
82 | apoptotic cell clearance (GO:0043277) | 2.39384171 |
83 | cell adhesion mediated by integrin (GO:0033627) | 2.39160313 |
84 | amyloid precursor protein catabolic process (GO:0042987) | 2.38063746 |
85 | B cell mediated immunity (GO:0019724) | 2.37664958 |
86 | defense response to fungus (GO:0050832) | 2.36570162 |
87 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.36489568 |
88 | response to host immune response (GO:0052572) | 2.36408311 |
89 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.36408311 |
90 | regulation of vitamin metabolic process (GO:0030656) | 2.36105403 |
91 | embryonic process involved in female pregnancy (GO:0060136) | 2.35145409 |
92 | viral transcription (GO:0019083) | 2.34997057 |
93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.34216083 |
94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.34075278 |
95 | response to host (GO:0075136) | 2.34075278 |
96 | response to host defenses (GO:0052200) | 2.34075278 |
97 | pinocytosis (GO:0006907) | 2.34073864 |
98 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.32597254 |
99 | amino sugar catabolic process (GO:0046348) | 2.32546654 |
100 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.32208964 |
101 | nuclear pore organization (GO:0006999) | 2.31912586 |
102 | regulation of leukocyte degranulation (GO:0043300) | 2.31654792 |
103 | regulation of cellular extravasation (GO:0002691) | 2.31300011 |
104 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.31208346 |
105 | proline biosynthetic process (GO:0006561) | 2.31151605 |
106 | trophectodermal cell differentiation (GO:0001829) | 2.31140243 |
107 | skin morphogenesis (GO:0043589) | 2.29711456 |
108 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.29178928 |
109 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.28732869 |
110 | endothelial tube morphogenesis (GO:0061154) | 2.27471320 |
111 | morphogenesis of an endothelium (GO:0003159) | 2.27471320 |
112 | mannose metabolic process (GO:0006013) | 2.27089816 |
113 | leukocyte aggregation (GO:0070486) | 2.26452283 |
114 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.26278374 |
115 | protein localization to chromosome, centromeric region (GO:0071459) | 2.25995913 |
116 | membrane disassembly (GO:0030397) | 2.24988900 |
117 | nuclear envelope disassembly (GO:0051081) | 2.24988900 |
118 | response to interferon-beta (GO:0035456) | 2.24826813 |
119 | cortical actin cytoskeleton organization (GO:0030866) | 2.24098854 |
120 | interferon-gamma secretion (GO:0072643) | 2.23786053 |
121 | chromatin assembly (GO:0031497) | 2.23716390 |
122 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.23622092 |
123 | NLS-bearing protein import into nucleus (GO:0006607) | 2.23557735 |
124 | translational termination (GO:0006415) | 2.23517350 |
125 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.23132752 |
126 | response to peptidoglycan (GO:0032494) | 2.22793767 |
127 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.22561767 |
128 | regulation of cholesterol storage (GO:0010885) | 2.21989964 |
129 | glucose catabolic process (GO:0006007) | 2.21165510 |
130 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.21100133 |
131 | cell-substrate junction assembly (GO:0007044) | 2.21041249 |
132 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.20748974 |
133 | protein localization to endosome (GO:0036010) | 2.20349517 |
134 | positive regulation of lamellipodium organization (GO:1902745) | 2.19910088 |
135 | hyaluronan catabolic process (GO:0030214) | 2.19515061 |
136 | negative regulation of cell size (GO:0045792) | 2.19443747 |
137 | granulocyte activation (GO:0036230) | 2.19344730 |
138 | negative regulation of necroptotic process (GO:0060546) | 2.18714686 |
139 | response to muramyl dipeptide (GO:0032495) | 2.18400864 |
140 | endodermal cell differentiation (GO:0035987) | 2.18117473 |
141 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.17913313 |
142 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.17840599 |
143 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.17658284 |
144 | germinal center formation (GO:0002467) | 2.17635485 |
145 | leukocyte cell-cell adhesion (GO:0007159) | 2.17580605 |
146 | negative regulation of fatty acid transport (GO:2000192) | 2.17480974 |
147 | positive thymic T cell selection (GO:0045059) | 2.16138289 |
148 | detection of external biotic stimulus (GO:0098581) | 2.15905170 |
149 | regulation of RIG-I signaling pathway (GO:0039535) | 2.15695157 |
150 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.15673079 |
151 | pentose metabolic process (GO:0019321) | 2.15149788 |
152 | positive regulation of B cell differentiation (GO:0045579) | 2.14891940 |
153 | regulation of mast cell degranulation (GO:0043304) | 2.14860649 |
154 | establishment of endothelial barrier (GO:0061028) | 2.14507436 |
155 | respiratory burst (GO:0045730) | 2.13020793 |
156 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.12498476 |
157 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.12278917 |
158 | defense response to protozoan (GO:0042832) | 2.12218904 |
159 | regulation of translational termination (GO:0006449) | 2.11663588 |
160 | * apoptotic process involved in morphogenesis (GO:0060561) | 2.09566844 |
161 | positive regulation of interferon-beta production (GO:0032728) | 2.08701924 |
162 | natural killer cell differentiation (GO:0001779) | 2.08100447 |
163 | receptor catabolic process (GO:0032801) | 2.05365845 |
164 | regulation of gamma-delta T cell activation (GO:0046643) | 2.05322194 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.21434359 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.85733148 |
3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.41061139 |
4 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.29669891 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 3.08365011 |
6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.86145445 |
7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.69242091 |
8 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.51382274 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.34839918 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12773154 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.10352682 |
12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.09931035 |
13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.02245831 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.95763918 |
15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94023776 |
16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92052720 |
17 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90701334 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89755953 |
19 | MAF_26560356_Chip-Seq_TH1_Human | 1.86882758 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85812284 |
21 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77442306 |
22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.77211540 |
23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.77013791 |
24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75909942 |
25 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74723803 |
26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74130930 |
27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73578858 |
28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71842397 |
29 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.68855653 |
30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.68223279 |
31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.64544817 |
32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.61657969 |
33 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.60807354 |
34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.59435999 |
35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59214348 |
36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56631152 |
37 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56063863 |
38 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55412580 |
39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53651370 |
40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.52935232 |
41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52399010 |
42 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.48903418 |
43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47637705 |
44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.44496098 |
45 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.44304540 |
46 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.43398620 |
47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42964927 |
48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41370930 |
49 | * MYB_26560356_Chip-Seq_TH2_Human | 1.40287524 |
50 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.37652119 |
51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36311842 |
52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36181041 |
53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35211993 |
54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.34583887 |
55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34502840 |
56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34179892 |
57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33348622 |
58 | ATF3_27146783_Chip-Seq_COLON_Human | 1.32623990 |
59 | MYB_26560356_Chip-Seq_TH1_Human | 1.32169961 |
60 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30706486 |
61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29754066 |
62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28560471 |
63 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27797607 |
64 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.26207540 |
65 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.25656737 |
66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.24774797 |
67 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24714752 |
68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24346555 |
69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.23339666 |
70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22530013 |
71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22402117 |
72 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21690465 |
73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21348205 |
74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21121778 |
75 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20723926 |
76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20599392 |
77 | MAF_26560356_Chip-Seq_TH2_Human | 1.20061541 |
78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19465318 |
79 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18946374 |
80 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.17373709 |
81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17262946 |
82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.16695515 |
83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16103629 |
84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15811119 |
85 | P68_20966046_ChIP-Seq_HELA_Human | 1.15323081 |
86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15149449 |
87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15100151 |
88 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14768256 |
89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14547903 |
90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13740348 |
91 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13333150 |
92 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12584487 |
93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11735662 |
94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11230859 |
95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11194591 |
96 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10511852 |
97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10231144 |
98 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10099690 |
99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08741298 |
100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07916990 |
101 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07474882 |
102 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07272138 |
103 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07248245 |
104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07105021 |
105 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06854373 |
106 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05081150 |
107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04659107 |
108 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04220737 |
109 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04050505 |
110 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.01685562 |
111 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00944894 |
112 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00910496 |
113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00108209 |
114 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.99423947 |
115 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99102212 |
116 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98018516 |
117 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97722869 |
118 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96128751 |
119 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95564477 |
120 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95346939 |
121 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.93900497 |
122 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.92211061 |
123 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90584016 |
124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.89972156 |
125 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89466801 |
126 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89171638 |
127 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88905381 |
128 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.88245843 |
129 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87513915 |
130 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.87291747 |
131 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.86655416 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003705_abnormal_hypodermis_morpholog | 3.54134681 |
2 | MP0010352_gastrointestinal_tract_polyps | 3.28097875 |
3 | MP0005451_abnormal_body_composition | 3.23475863 |
4 | MP0003303_peritoneal_inflammation | 3.18023367 |
5 | MP0003300_gastrointestinal_ulcer | 2.93231154 |
6 | MP0008260_abnormal_autophagy | 2.64093262 |
7 | MP0005076_abnormal_cell_differentiation | 2.42082064 |
8 | MP0003566_abnormal_cell_adhesion | 2.38443586 |
9 | MP0003436_decreased_susceptibility_to | 2.32514092 |
10 | MP0010307_abnormal_tumor_latency | 2.25657229 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.18739497 |
12 | MP0009278_abnormal_bone_marrow | 2.04060707 |
13 | MP0009840_abnormal_foam_cell | 1.90237697 |
14 | MP0003806_abnormal_nucleotide_metabolis | 1.86839835 |
15 | MP0003724_increased_susceptibility_to | 1.84741466 |
16 | MP0001835_abnormal_antigen_presentation | 1.79510551 |
17 | MP0002796_impaired_skin_barrier | 1.78184360 |
18 | MP0005023_abnormal_wound_healing | 1.77319560 |
19 | MP0000685_abnormal_immune_system | 1.76408412 |
20 | MP0004947_skin_inflammation | 1.66052814 |
21 | MP0000490_abnormal_crypts_of | 1.64676250 |
22 | MP0006054_spinal_hemorrhage | 1.61603684 |
23 | MP0004808_abnormal_hematopoietic_stem | 1.58906406 |
24 | MP0004264_abnormal_extraembryonic_tissu | 1.53858239 |
25 | MP0006082_CNS_inflammation | 1.53280584 |
26 | * MP0002452_abnormal_antigen_presenting | 1.51338056 |
27 | MP0002396_abnormal_hematopoietic_system | 1.50951152 |
28 | MP0005387_immune_system_phenotype | 1.50538335 |
29 | MP0001790_abnormal_immune_system | 1.50538335 |
30 | MP0003448_altered_tumor_morphology | 1.49334403 |
31 | MP0010155_abnormal_intestine_physiology | 1.49329883 |
32 | * MP0001800_abnormal_humoral_immune | 1.49011746 |
33 | MP0005025_abnormal_response_to | 1.46477855 |
34 | MP0002419_abnormal_innate_immunity | 1.44818932 |
35 | MP0005397_hematopoietic_system_phenotyp | 1.44588448 |
36 | MP0001545_abnormal_hematopoietic_system | 1.44588448 |
37 | MP0000733_abnormal_muscle_development | 1.44336929 |
38 | MP0002877_abnormal_melanocyte_morpholog | 1.42502881 |
39 | MP0002405_respiratory_system_inflammati | 1.41068535 |
40 | MP0000858_altered_metastatic_potential | 1.40955105 |
41 | * MP0005000_abnormal_immune_tolerance | 1.39991690 |
42 | MP0001849_ear_inflammation | 1.39245876 |
43 | MP0003091_abnormal_cell_migration | 1.38678065 |
44 | MP0009785_altered_susceptibility_to | 1.36223352 |
45 | MP0001533_abnormal_skeleton_physiology | 1.35675037 |
46 | * MP0002398_abnormal_bone_marrow | 1.33956683 |
47 | MP0010234_abnormal_vibrissa_follicle | 1.33395202 |
48 | MP0003075_altered_response_to | 1.33289599 |
49 | MP0005501_abnormal_skin_physiology | 1.33227917 |
50 | MP0005058_abnormal_lysosome_morphology | 1.32185317 |
51 | * MP0001819_abnormal_immune_cell | 1.29639414 |
52 | * MP0002420_abnormal_adaptive_immunity | 1.29158239 |
53 | * MP0002723_abnormal_immune_serum | 1.26131435 |
54 | * MP0005464_abnormal_platelet_physiology | 1.26052892 |
55 | MP0003183_abnormal_peptide_metabolism | 1.25534694 |
56 | MP0003693_abnormal_embryo_hatching | 1.22981526 |
57 | MP0002166_altered_tumor_susceptibility | 1.21314477 |
58 | * MP0002722_abnormal_immune_system | 1.20718185 |
59 | * MP0009333_abnormal_splenocyte_physiolog | 1.20135374 |
60 | MP0003453_abnormal_keratinocyte_physiol | 1.19282988 |
61 | MP0004957_abnormal_blastocyst_morpholog | 1.19030375 |
62 | MP0005257_abnormal_intraocular_pressure | 1.17258577 |
63 | MP0003111_abnormal_nucleus_morphology | 1.16878198 |
64 | MP0001730_embryonic_growth_arrest | 1.16291451 |
65 | MP0001216_abnormal_epidermal_layer | 1.15966091 |
66 | * MP0000716_abnormal_immune_system | 1.15692788 |
67 | * MP0000689_abnormal_spleen_morphology | 1.14362181 |
68 | MP0003279_aneurysm | 1.13287042 |
69 | MP0003077_abnormal_cell_cycle | 1.12114510 |
70 | MP0000350_abnormal_cell_proliferation | 1.11270578 |
71 | MP0004510_myositis | 1.10460275 |
72 | * MP0002429_abnormal_blood_cell | 1.09891512 |
73 | MP0001873_stomach_inflammation | 1.08966053 |
74 | MP0005166_decreased_susceptibility_to | 1.07240376 |
75 | MP0001915_intracranial_hemorrhage | 1.05765131 |
76 | MP0000465_gastrointestinal_hemorrhage | 1.05640285 |
77 | MP0003172_abnormal_lysosome_physiology | 1.05409773 |
78 | MP0004858_abnormal_nervous_system | 1.04836937 |
79 | MP0000678_abnormal_parathyroid_gland | 1.04669585 |
80 | MP0005310_abnormal_salivary_gland | 1.03460497 |
81 | MP0002006_tumorigenesis | 1.03296582 |
82 | MP0004197_abnormal_fetal_growth/weight/ | 1.02959117 |
83 | * MP0001845_abnormal_inflammatory_respons | 1.02663292 |
84 | MP0004185_abnormal_adipocyte_glucose | 1.02347780 |
85 | MP0001958_emphysema | 1.01574091 |
86 | MP0002086_abnormal_extraembryonic_tissu | 1.01346078 |
87 | MP0009053_abnormal_anal_canal | 0.99307032 |
88 | MP0000703_abnormal_thymus_morphology | 0.99218793 |
89 | MP0002148_abnormal_hypersensitivity_rea | 0.98559766 |
90 | MP0009764_decreased_sensitivity_to | 0.96947771 |
91 | MP0002139_abnormal_hepatobiliary_system | 0.96656495 |
92 | MP0002019_abnormal_tumor_incidence | 0.96591157 |
93 | MP0000343_altered_response_to | 0.96310007 |
94 | MP0005671_abnormal_response_to | 0.94180050 |
95 | MP0003984_embryonic_growth_retardation | 0.93882423 |
96 | MP0001853_heart_inflammation | 0.93840288 |
97 | MP0000604_amyloidosis | 0.93219012 |
98 | MP0002088_abnormal_embryonic_growth/wei | 0.92361599 |
99 | MP0000477_abnormal_intestine_morphology | 0.90232075 |
100 | MP0005275_abnormal_skin_tensile | 0.89988447 |
101 | MP0003866_abnormal_defecation | 0.88724261 |
102 | MP0001672_abnormal_embryogenesis/_devel | 0.85354469 |
103 | MP0005380_embryogenesis_phenotype | 0.85354469 |
104 | MP0005165_increased_susceptibility_to | 0.85262578 |
105 | MP0005623_abnormal_meninges_morphology | 0.85207207 |
106 | MP0002998_abnormal_bone_remodeling | 0.84742406 |
107 | MP0010094_abnormal_chromosome_stability | 0.83232964 |
108 | MP0005390_skeleton_phenotype | 0.81688261 |
109 | MP0002080_prenatal_lethality | 0.81425601 |
110 | MP0003763_abnormal_thymus_physiology | 0.80928428 |
111 | MP0003191_abnormal_cellular_cholesterol | 0.80548344 |
112 | MP0001697_abnormal_embryo_size | 0.80256683 |
113 | MP0002254_reproductive_system_inflammat | 0.78920997 |
114 | MP0000750_abnormal_muscle_regeneration | 0.78829920 |
115 | MP0003828_pulmonary_edema | 0.77795830 |
116 | MP0002925_abnormal_cardiovascular_devel | 0.77577353 |
117 | MP0000767_abnormal_smooth_muscle | 0.77552731 |
118 | MP0009931_abnormal_skin_appearance | 0.76785188 |
119 | MP0008469_abnormal_protein_level | 0.76305792 |
120 | MP0003329_amyloid_beta_deposits | 0.74473472 |
121 | MP0001663_abnormal_digestive_system | 0.73589566 |
122 | * MP0000313_abnormal_cell_death | 0.73402036 |
123 | MP0009763_increased_sensitivity_to | 0.73360074 |
124 | MP0002132_abnormal_respiratory_system | 0.72736204 |
125 | MP0008004_abnormal_stomach_pH | 0.72312997 |
126 | MP0005360_urolithiasis | 0.71880374 |
127 | MP0000609_abnormal_liver_physiology | 0.71748756 |
128 | MP0005319_abnormal_enzyme/_coenzyme | 0.71456031 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 3.44867716 |
2 | Increased density of long bones (HP:0006392) | 3.32936802 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26948141 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26948141 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26948141 |
6 | Eczematoid dermatitis (HP:0000976) | 3.24182247 |
7 | Cerebral aneurysm (HP:0004944) | 2.91264313 |
8 | Peritonitis (HP:0002586) | 2.89816062 |
9 | Recurrent abscess formation (HP:0002722) | 2.82880641 |
10 | Cellulitis (HP:0100658) | 2.78095888 |
11 | Premature rupture of membranes (HP:0001788) | 2.72082842 |
12 | Vacuolated lymphocytes (HP:0001922) | 2.68984855 |
13 | Autoimmune thrombocytopenia (HP:0001973) | 2.66457479 |
14 | Cervical subluxation (HP:0003308) | 2.65640978 |
15 | Increased IgM level (HP:0003496) | 2.62266242 |
16 | Loss of speech (HP:0002371) | 2.59170486 |
17 | Abnormal platelet volume (HP:0011876) | 2.52595525 |
18 | Ulnar bowing (HP:0003031) | 2.51624048 |
19 | Malnutrition (HP:0004395) | 2.50017406 |
20 | Shallow orbits (HP:0000586) | 2.48409307 |
21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48187730 |
22 | Systemic lupus erythematosus (HP:0002725) | 2.46960055 |
23 | Osteolytic defects of the hand bones (HP:0009699) | 2.42538237 |
24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.42538237 |
25 | Ragged-red muscle fibers (HP:0003200) | 2.42493153 |
26 | Recurrent viral infections (HP:0004429) | 2.41200686 |
27 | Recurrent bacterial skin infections (HP:0005406) | 2.41200606 |
28 | Nasal polyposis (HP:0100582) | 2.35100651 |
29 | Ankle contracture (HP:0006466) | 2.34566048 |
30 | Colitis (HP:0002583) | 2.33110785 |
31 | Hepatosplenomegaly (HP:0001433) | 2.32840798 |
32 | Recurrent fungal infections (HP:0002841) | 2.30608006 |
33 | Increased mean platelet volume (HP:0011877) | 2.30420975 |
34 | Hypertensive crisis (HP:0100735) | 2.28266372 |
35 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27680206 |
36 | Genu recurvatum (HP:0002816) | 2.26977798 |
37 | Gastrointestinal stroma tumor (HP:0100723) | 2.26970117 |
38 | Chronic otitis media (HP:0000389) | 2.24936083 |
39 | Interstitial pulmonary disease (HP:0006530) | 2.23973646 |
40 | Meningitis (HP:0001287) | 2.23831070 |
41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.20361306 |
42 | Recurrent skin infections (HP:0001581) | 2.19713564 |
43 | Abnormality of the nasal mucosa (HP:0000433) | 2.15751258 |
44 | Abnormality of the peritoneum (HP:0002585) | 2.15509885 |
45 | Rough bone trabeculation (HP:0100670) | 2.15081852 |
46 | Myositis (HP:0100614) | 2.14991328 |
47 | Axonal loss (HP:0003447) | 2.13595763 |
48 | Hyperacusis (HP:0010780) | 2.12630971 |
49 | Purpura (HP:0000979) | 2.12500471 |
50 | Increased cerebral lipofuscin (HP:0011813) | 2.11379555 |
51 | Pustule (HP:0200039) | 2.10732966 |
52 | Dilatation of the ascending aorta (HP:0005111) | 2.10682554 |
53 | Polygenic inheritance (HP:0010982) | 2.10432027 |
54 | Distal lower limb amyotrophy (HP:0008944) | 2.09305452 |
55 | Thrombocytosis (HP:0001894) | 2.08955591 |
56 | Hypergammaglobulinemia (HP:0010702) | 2.08384949 |
57 | Cutaneous melanoma (HP:0012056) | 2.07441588 |
58 | Premature loss of primary teeth (HP:0006323) | 2.07070418 |
59 | Distal lower limb muscle weakness (HP:0009053) | 2.06767316 |
60 | Progressive muscle weakness (HP:0003323) | 2.06551569 |
61 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06218899 |
62 | Spontaneous hematomas (HP:0007420) | 2.06218867 |
63 | Distal upper limb amyotrophy (HP:0007149) | 2.03093944 |
64 | Upper limb amyotrophy (HP:0009129) | 2.03093944 |
65 | Hematochezia (HP:0002573) | 2.00947739 |
66 | Fatigue (HP:0012378) | 2.00916608 |
67 | Mitral valve prolapse (HP:0001634) | 2.00831866 |
68 | Amyloidosis (HP:0011034) | 2.00081952 |
69 | Vasculitis (HP:0002633) | 2.00067433 |
70 | Trismus (HP:0000211) | 1.98891697 |
71 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98612453 |
72 | Aortic aneurysm (HP:0004942) | 1.95874359 |
73 | Rectal prolapse (HP:0002035) | 1.95805265 |
74 | Abnormality of macrophages (HP:0004311) | 1.95079159 |
75 | Bone pain (HP:0002653) | 1.93941186 |
76 | Petechiae (HP:0000967) | 1.93768427 |
77 | Hyperparathyroidism (HP:0000843) | 1.93540852 |
78 | Thick nail (HP:0001805) | 1.93016767 |
79 | Hand muscle atrophy (HP:0009130) | 1.92643428 |
80 | Abnormal blistering of the skin (HP:0008066) | 1.92256073 |
81 | Abnormal trabecular bone morphology (HP:0100671) | 1.92000608 |
82 | Slender build (HP:0001533) | 1.90786999 |
83 | Gastrointestinal infarctions (HP:0005244) | 1.90052870 |
84 | Agammaglobulinemia (HP:0004432) | 1.89949494 |
85 | Increased connective tissue (HP:0009025) | 1.89544527 |
86 | Radial bowing (HP:0002986) | 1.88392717 |
87 | Papilloma (HP:0012740) | 1.87996432 |
88 | Verrucae (HP:0200043) | 1.87996432 |
89 | Abnormality of nail color (HP:0100643) | 1.85876526 |
90 | Gastrointestinal inflammation (HP:0004386) | 1.85305972 |
91 | Increased IgE level (HP:0003212) | 1.85044849 |
92 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.84748258 |
93 | Mediastinal lymphadenopathy (HP:0100721) | 1.84360424 |
94 | Flat acetabular roof (HP:0003180) | 1.84210551 |
95 | Onycholysis (HP:0001806) | 1.83913534 |
96 | Thin bony cortex (HP:0002753) | 1.82913152 |
97 | Gastrointestinal dysmotility (HP:0002579) | 1.82909021 |
98 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82399884 |
99 | Obstructive lung disease (HP:0006536) | 1.82399884 |
100 | Aortic dissection (HP:0002647) | 1.82395512 |
101 | Deviation of the thumb (HP:0009603) | 1.81654454 |
102 | Myopathic facies (HP:0002058) | 1.81543595 |
103 | Achilles tendon contracture (HP:0001771) | 1.80915770 |
104 | Progressive neurologic deterioration (HP:0002344) | 1.80853365 |
105 | Myocardial infarction (HP:0001658) | 1.80778884 |
106 | Autoimmune hemolytic anemia (HP:0001890) | 1.80509836 |
107 | Nail dystrophy (HP:0008404) | 1.80210751 |
108 | Chest pain (HP:0100749) | 1.80145111 |
109 | Prolonged neonatal jaundice (HP:0006579) | 1.80114610 |
110 | Impaired platelet aggregation (HP:0003540) | 1.80027646 |
111 | Abnormal platelet function (HP:0011869) | 1.80027646 |
112 | Persistence of primary teeth (HP:0006335) | 1.79832212 |
113 | Selective tooth agenesis (HP:0001592) | 1.79768726 |
114 | Hemorrhage of the eye (HP:0011885) | 1.79552305 |
115 | Vertebral compression fractures (HP:0002953) | 1.78353814 |
116 | Lymphopenia (HP:0001888) | 1.78336507 |
117 | Disproportionate tall stature (HP:0001519) | 1.78117443 |
118 | Bowed forearm bones (HP:0003956) | 1.78108825 |
119 | Bowing of the arm (HP:0006488) | 1.78108825 |
120 | Aneurysm (HP:0002617) | 1.75455584 |
121 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75087167 |
122 | Mucopolysacchariduria (HP:0008155) | 1.75087167 |
123 | Encephalitis (HP:0002383) | 1.74775299 |
124 | Subacute progressive viral hepatitis (HP:0006572) | 1.74696484 |
125 | Emphysema (HP:0002097) | 1.74498131 |
126 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.74112061 |
127 | Short 4th metacarpal (HP:0010044) | 1.74112061 |
128 | Inflammation of the large intestine (HP:0002037) | 1.73451167 |
129 | Orchitis (HP:0100796) | 1.70057393 |
130 | Skin rash (HP:0000988) | 1.69986700 |
131 | Atrophic scars (HP:0001075) | 1.69414801 |
132 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.69128793 |
133 | Periodontitis (HP:0000704) | 1.68915585 |
134 | Increased serum ferritin (HP:0003281) | 1.68283273 |
135 | Optic neuritis (HP:0100653) | 1.68277480 |
136 | Retrobulbar optic neuritis (HP:0100654) | 1.68277480 |
137 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68274722 |
138 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68274722 |
139 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68274722 |
140 | Gingivitis (HP:0000230) | 1.68005870 |
141 | Disinhibition (HP:0000734) | 1.65724743 |
142 | Hypertriglyceridemia (HP:0002155) | 1.65345512 |
143 | High pitched voice (HP:0001620) | 1.65120027 |
144 | Abdominal distention (HP:0003270) | 1.65017190 |
145 | Urticaria (HP:0001025) | 1.64913304 |
146 | Osteomyelitis (HP:0002754) | 1.64606944 |
147 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.64593310 |
148 | IgA deficiency (HP:0002720) | 1.64461965 |
149 | Dysostosis multiplex (HP:0000943) | 1.64113256 |
150 | Reticulocytosis (HP:0001923) | 1.63619661 |
151 | Bicuspid aortic valve (HP:0001647) | 1.63529289 |
152 | Arterial thrombosis (HP:0004420) | 1.63034375 |
153 | Abnormality of the Achilles tendon (HP:0005109) | 1.62614060 |
154 | Abnormality of the acetabulum (HP:0003170) | 1.62278242 |
155 | IgM deficiency (HP:0002850) | 1.62145205 |
156 | Frequent falls (HP:0002359) | 1.61661719 |
157 | Bladder diverticulum (HP:0000015) | 1.60958070 |
158 | Blue sclerae (HP:0000592) | 1.60159630 |
159 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.59523892 |
160 | Gastrointestinal carcinoma (HP:0002672) | 1.59523892 |
161 | Proximal placement of thumb (HP:0009623) | 1.57436113 |
162 | Severe short stature (HP:0003510) | 1.57333905 |
163 | Skin ulcer (HP:0200042) | 1.57245727 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 3.97164239 |
2 | PKN2 | 3.65772182 |
3 | EEF2K | 3.53928259 |
4 | ERN1 | 3.25580112 |
5 | PRPF4B | 3.13625401 |
6 | MAP3K10 | 3.01923323 |
7 | SMG1 | 2.99853326 |
8 | IRAK3 | 2.88437768 |
9 | CDK12 | 2.76949859 |
10 | MAP4K1 | 2.62297585 |
11 | TTN | 2.38609363 |
12 | STK10 | 2.27118908 |
13 | LRRK2 | 2.08357587 |
14 | TAOK2 | 1.95223966 |
15 | RIPK4 | 1.93725408 |
16 | PTK6 | 1.93122397 |
17 | IRAK4 | 1.80654009 |
18 | TESK2 | 1.64072107 |
19 | GRK6 | 1.61583929 |
20 | PAK4 | 1.54822922 |
21 | EPHB1 | 1.53051036 |
22 | RPS6KA4 | 1.52618270 |
23 | ARAF | 1.48929713 |
24 | SCYL2 | 1.46444551 |
25 | TBK1 | 1.44982980 |
26 | TYK2 | 1.40380567 |
27 | RIPK1 | 1.39911485 |
28 | MAP3K14 | 1.39832068 |
29 | VRK2 | 1.38844674 |
30 | TESK1 | 1.38639694 |
31 | NEK2 | 1.38625791 |
32 | BLK | 1.36031336 |
33 | MAP3K8 | 1.26368118 |
34 | RPS6KB2 | 1.22301563 |
35 | CDK6 | 1.21725815 |
36 | PIM2 | 1.20901383 |
37 | SIK1 | 1.20230269 |
38 | ALK | 1.19794524 |
39 | JAK3 | 1.14097740 |
40 | MAP3K1 | 1.10435834 |
41 | LMTK2 | 1.09542316 |
42 | PIM1 | 1.06009536 |
43 | MAP2K3 | 1.05285690 |
44 | FLT3 | 1.04785522 |
45 | KIT | 1.04017114 |
46 | CSK | 1.04002048 |
47 | NME2 | 1.03784253 |
48 | SIK3 | 1.03164329 |
49 | BUB1 | 1.03078516 |
50 | CDK4 | 1.02733391 |
51 | BTK | 1.02346130 |
52 | ZAP70 | 1.01752930 |
53 | PDGFRA | 1.01337888 |
54 | EPHA2 | 1.01135950 |
55 | ICK | 0.99718469 |
56 | CDC7 | 0.98158797 |
57 | CSF1R | 0.96449816 |
58 | MAP3K11 | 0.95965412 |
59 | CAMK1D | 0.95535527 |
60 | DMPK | 0.93579536 |
61 | MTOR | 0.92985153 |
62 | STK3 | 0.90323487 |
63 | KSR2 | 0.89739406 |
64 | PAK2 | 0.88419580 |
65 | STK4 | 0.83952088 |
66 | HCK | 0.81852569 |
67 | PBK | 0.79850194 |
68 | ILK | 0.79340541 |
69 | CDC42BPA | 0.79120477 |
70 | FGFR4 | 0.77614057 |
71 | CDK7 | 0.77002585 |
72 | DDR2 | 0.74829786 |
73 | LIMK1 | 0.74668045 |
74 | JAK1 | 0.74380441 |
75 | PTK2 | 0.73647350 |
76 | MAP3K13 | 0.72894332 |
77 | BCKDK | 0.72258851 |
78 | PRKD2 | 0.70224039 |
79 | KDR | 0.69208891 |
80 | PRKG2 | 0.67478673 |
81 | TAOK1 | 0.66559851 |
82 | IRAK2 | 0.66446063 |
83 | FGFR3 | 0.65804777 |
84 | PDPK1 | 0.65312492 |
85 | ABL2 | 0.65262107 |
86 | NEK1 | 0.64371172 |
87 | TGFBR2 | 0.63703696 |
88 | MST1R | 0.60748599 |
89 | CHUK | 0.60622122 |
90 | FES | 0.60161201 |
91 | MATK | 0.59684948 |
92 | TRPM7 | 0.59576888 |
93 | SIK2 | 0.57407824 |
94 | TGFBR1 | 0.56825998 |
95 | IKBKE | 0.56790423 |
96 | BRAF | 0.56770002 |
97 | IKBKB | 0.56403872 |
98 | MAPKAPK2 | 0.55227680 |
99 | MARK3 | 0.54360156 |
100 | LCK | 0.54272514 |
101 | FGR | 0.53106070 |
102 | STK16 | 0.52980921 |
103 | PAK1 | 0.52156829 |
104 | ITK | 0.51791406 |
105 | JAK2 | 0.51711238 |
106 | LATS1 | 0.51177904 |
107 | LYN | 0.51131338 |
108 | SYK | 0.50576465 |
109 | DAPK1 | 0.49196569 |
110 | DYRK1B | 0.48976551 |
111 | RPS6KA6 | 0.48386102 |
112 | PDGFRB | 0.47897809 |
113 | CLK1 | 0.47835124 |
114 | MAP3K6 | 0.47542813 |
115 | CAMK1G | 0.47503270 |
116 | RPS6KC1 | 0.46667976 |
117 | RPS6KL1 | 0.46667976 |
118 | MAPK11 | 0.46265840 |
119 | AURKB | 0.45986656 |
120 | MAPKAPK3 | 0.45050128 |
121 | HIPK2 | 0.44424914 |
122 | EGFR | 0.43798947 |
123 | MAP2K2 | 0.43206977 |
124 | RPS6KA1 | 0.41842935 |
125 | MAP3K5 | 0.41612677 |
126 | NEK9 | 0.40954513 |
127 | RPS6KA2 | 0.40044562 |
128 | * BMX | 0.39803648 |
129 | DAPK3 | 0.39787073 |
130 | MET | 0.39683773 |
131 | MAP3K3 | 0.39108893 |
132 | PDK1 | 0.39067666 |
133 | AURKA | 0.38845875 |
134 | TTK | 0.38139949 |
135 | MOS | 0.37734677 |
136 | RET | 0.36321702 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31240143 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 1.94938811 |
3 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.89006699 |
4 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.87699147 |
5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.78876291 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.73188391 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72328066 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.71587238 |
9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69720251 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.66946034 |
11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63366102 |
12 | Shigellosis_Homo sapiens_hsa05131 | 1.60685484 |
13 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.58254843 |
14 | Legionellosis_Homo sapiens_hsa05134 | 1.56345499 |
15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55793778 |
16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.54820570 |
17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53996136 |
18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.51791492 |
19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.45447787 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42357908 |
21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.41487470 |
22 | DNA replication_Homo sapiens_hsa03030 | 1.40699947 |
23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39545540 |
24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.39138910 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38776754 |
26 | Measles_Homo sapiens_hsa05162 | 1.38338336 |
27 | * Apoptosis_Homo sapiens_hsa04210 | 1.37565032 |
28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.33557239 |
29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.31371887 |
30 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.31085830 |
31 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.30821727 |
32 | Hepatitis B_Homo sapiens_hsa05161 | 1.30472316 |
33 | Tuberculosis_Homo sapiens_hsa05152 | 1.29463736 |
34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28306877 |
35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.27039454 |
36 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 1.26596646 |
37 | Bladder cancer_Homo sapiens_hsa05219 | 1.26055694 |
38 | Malaria_Homo sapiens_hsa05144 | 1.25294271 |
39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25101630 |
40 | Salmonella infection_Homo sapiens_hsa05132 | 1.24469790 |
41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24202830 |
42 | Pertussis_Homo sapiens_hsa05133 | 1.22177777 |
43 | Adherens junction_Homo sapiens_hsa04520 | 1.21976524 |
44 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.21280768 |
45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19073392 |
46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18475933 |
47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18042277 |
48 | Amoebiasis_Homo sapiens_hsa05146 | 1.16856707 |
49 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15603529 |
50 | Focal adhesion_Homo sapiens_hsa04510 | 1.15280822 |
51 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.14363025 |
52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12530542 |
53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11131624 |
54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.10855881 |
55 | Proteasome_Homo sapiens_hsa03050 | 1.09627251 |
56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08746754 |
57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07717928 |
58 | Influenza A_Homo sapiens_hsa05164 | 1.06558729 |
59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.04363897 |
60 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04085503 |
61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.03518813 |
62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99564357 |
63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99233050 |
64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98244539 |
65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97990485 |
66 | Cell cycle_Homo sapiens_hsa04110 | 0.97148663 |
67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96512919 |
68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96018463 |
69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95147908 |
70 | Platelet activation_Homo sapiens_hsa04611 | 0.94667211 |
71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94321798 |
72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93170580 |
73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92499519 |
74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.92124899 |
75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91548752 |
76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91059444 |
77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90599044 |
78 | Phagosome_Homo sapiens_hsa04145 | 0.90102298 |
79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89793877 |
80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89256105 |
81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88898741 |
82 | Lysosome_Homo sapiens_hsa04142 | 0.87970137 |
83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87073939 |
84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86995085 |
85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86343094 |
86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81156712 |
87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77560943 |
88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76797371 |
89 | Hepatitis C_Homo sapiens_hsa05160 | 0.76622119 |
90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75846592 |
91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74985814 |
92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.74946599 |
93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74782806 |
94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74096852 |
95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72317949 |
96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71111727 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.70703083 |
98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.70668970 |
99 | RNA transport_Homo sapiens_hsa03013 | 0.70132450 |
100 | Mismatch repair_Homo sapiens_hsa03430 | 0.70047761 |
101 | Base excision repair_Homo sapiens_hsa03410 | 0.69873980 |
102 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.69825835 |
103 | Insulin resistance_Homo sapiens_hsa04931 | 0.69606613 |
104 | Asthma_Homo sapiens_hsa05310 | 0.69382004 |
105 | Lysine degradation_Homo sapiens_hsa00310 | 0.67581356 |
106 | Ribosome_Homo sapiens_hsa03010 | 0.67437954 |
107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67304112 |
108 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.66529128 |
109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66431710 |
110 | Prion diseases_Homo sapiens_hsa05020 | 0.64951431 |
111 | Prostate cancer_Homo sapiens_hsa05215 | 0.64182068 |
112 | Spliceosome_Homo sapiens_hsa03040 | 0.63082240 |
113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62733943 |
114 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62135582 |
115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61605771 |
116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60175091 |
117 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59590997 |
118 | Glioma_Homo sapiens_hsa05214 | 0.59061437 |
119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57971790 |
120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57214967 |
121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56836416 |
122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55909665 |
123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55739517 |
124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55089491 |
125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51773097 |
126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49240350 |
127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48938441 |
128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48192260 |
129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45977627 |
130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45316871 |